High Tech Valuation
| 106190 Stock | KRW 14,090 60.00 0.42% |
At this time, the firm appears to be overvalued. High Tech Pharm retains a regular Real Value of W12020.4 per share. The prevalent price of the firm is W14090.0. Our model calculates the value of High Tech Pharm from evaluating the firm fundamentals such as Current Valuation of 137.37 B, return on asset of 6.0E-4, and Return On Equity of 0.0057 as well as inspecting its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that High Tech's price fluctuation is very steady at this time. Calculation of the real value of High Tech Pharm is based on 3 months time horizon. Increasing High Tech's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since High Tech is currently traded on the exchange, buyers and sellers on that exchange determine the market value of High Stock. However, High Tech's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 14090.0 | Real 12020.4 | Hype 14090.0 | Naive 13915.48 |
The real value of High Stock, also known as its intrinsic value, is the underlying worth of High Tech Pharm Company, which is reflected in its stock price. It is based on High Tech's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of High Tech's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of High Tech Pharm helps investors to forecast how High stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of High Tech more accurately as focusing exclusively on High Tech's fundamentals will not take into account other important factors: High Tech Total Value Analysis
High Tech Pharm is presently forecasted to have takeover price of 137.37 B with market capitalization of 100.16 B, debt of 5.98 B, and cash on hands of 11.27 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the High Tech fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
137.37 B | 100.16 B | 5.98 B | 11.27 B |
High Tech Investor Information
About 45.0% of the company shares are owned by insiders or employees . The company had not issued any dividends in recent years. Based on the key indicators obtained from High Tech's historical financial statements, High Tech Pharm is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.High Tech Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The current return on assets of High suggests not a very effective usage of assets in November.High Tech Ownership Allocation
The market capitalization of High Tech is W100.16 Billion. High Tech secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.High Tech Profitability Analysis
The company reported the revenue of 73.29 B. Net Loss for the year was (1.23 B) with profit before overhead, payroll, taxes, and interest of 1.31 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates High Tech's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in High Tech and how it compares across the competition.
About High Tech Valuation
The stock valuation mechanism determines High Tech's current worth on a weekly basis. Our valuation model uses a comparative analysis of High Tech. We calculate exposure to High Tech's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of High Tech's related companies.8 Steps to conduct High Tech's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates High Tech's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct High Tech's valuation analysis, follow these 8 steps:- Gather financial information: Obtain High Tech's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine High Tech's revenue streams: Identify High Tech's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research High Tech's industry and market trends, including the size of the market, growth rate, and competition.
- Establish High Tech's growth potential: Evaluate High Tech's management, business model, and growth potential.
- Determine High Tech's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate High Tech's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for High Stock analysis
When running High Tech's price analysis, check to measure High Tech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy High Tech is operating at the current time. Most of High Tech's value examination focuses on studying past and present price action to predict the probability of High Tech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move High Tech's price. Additionally, you may evaluate how the addition of High Tech to your portfolios can decrease your overall portfolio volatility.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |